Literature DB >> 21851425

Acral lesions of vitiligo: why are they resistant to photochemotherapy?

S M Esmat1, A M El-Tawdy, G A Hafez, O A Zeid, D M Abdel Halim, M A Saleh, T M Leheta, M Elmofty.   

Abstract

BACKGROUND: Acral lesions of vitiligo are usually resistant to conventional lines of treatment as well as surgical interventions.
OBJECTIVE: To clarify causes underlying resistance of acral lesions to pigmentation in vitiligo by studying some of the factors associated with mechanisms of repigmentation following photochemotherapy.
METHODS: The study included twenty patients with active vitiligo. Skin biopsies were taken from lesional and perilesional skin of areas expected to respond (trunk and proximal limb) and skin of acral areas, before and after PUVA therapy. Sections were stained with H and E, Melan-A, MHCII, CD1a, SCF and c-kit protein.
RESULTS: Before treatment acral areas showed significantly lower hair follicle density, melanocyte density, Langerhans cell (LC) density, epidermal MHCII expression, lesional SCF expression and perilesional c-kit expression. Following treatment with PUVA in both non-responsive acral and repigmenting non-acral lesions identical immunohistochemical changes in the form of significant decrease in LC density, epidermal MHC-II and SCF expression were observed.
CONCLUSION: The surprisingly similar histochemical changes in response to PUVA in acral and non-acral lesions did not manifest with clinical repigmentation except in non-acral ones. Factors such as inherent lower melanocyte density, lower melanocyte stem cell reservoirs and/or lower baseline epidermal stem cell factor may be considered as possible play makers in this respect.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2011        PMID: 21851425     DOI: 10.1111/j.1468-3083.2011.04215.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  10 in total

Review 1.  Melanocyte stem cells as potential therapeutics in skin disorders.

Authors:  Ju Hee Lee; David E Fisher
Journal:  Expert Opin Biol Ther       Date:  2014-08-08       Impact factor: 4.388

2.  Combination of Follicular and Epidermal Cell Suspension as a Novel Surgical Approach in Difficult-to-Treat Vitiligo: A Randomized Clinical Trial.

Authors:  Muhammed Razmi T; Ravinder Kumar; Seema Rani; Sendhil M Kumaran; Sushma Tanwar; Davinder Parsad
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

Review 3.  Skin Pigmentation and Pigmentary Disorders: Focus on Epidermal/Dermal Cross-Talk.

Authors:  Emanuela Bastonini; Daniela Kovacs; Mauro Picardo
Journal:  Ann Dermatol       Date:  2016-05-25       Impact factor: 1.444

Review 4.  Clinical and Molecular Aspects of Vitiligo Treatments.

Authors:  Anuradha Bishnoi; Davinder Parsad
Journal:  Int J Mol Sci       Date:  2018-05-18       Impact factor: 5.923

5.  Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.

Authors:  Saki Fukaya; Masahiro Kamata; Tomoko Kasanuki; Makoto Yokobori; Shintaro Takeoka; Kotaro Hayashi; Takamitsu Tanaka; Atsuko Fukuyasu; Takeko Ishikawa; Takamitsu Ohnishi; Satoshi Iimuro; Yayoi Tada; Shinichi Watanabe
Journal:  J Dermatol       Date:  2018-08-29       Impact factor: 4.005

6.  Quality of life of adult vitiligo patients using camouflage: A survey in a Chinese vitiligo community.

Authors:  Dian Chen; HsiaoHan Tuan; Eray Yihui Zhou; DeHua Liu; Yi Zhao
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

7.  Assessment of stem cell factor expression and its c-KIT receptor in patients with vitiligo.

Authors:  Dorota Wilamowska-Kokoszko; Karolina Łukasik; Jacek C Szepietowski; Dariusz J Skarżynski; Agnieszka Owczarczyk-Saczonek; Justyna Hlebowicz-Skrodzka; Waldemar J Placek
Journal:  Postepy Dermatol Alergol       Date:  2021-10-22       Impact factor: 1.664

8.  Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA.

Authors:  K Bibeau; A G Pandya; K Ezzedine; H Jones; J Gao; A Lindley; J E Harris
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06-14       Impact factor: 9.228

9.  The effects of tacrolimus plus phototherapy in the treatment of vitiligo: a meta-analysis.

Authors:  Yujie Dong; Qi Yang; Baofeng Guo; Jiajing Zhu; Xiaojie Sun
Journal:  Arch Dermatol Res       Date:  2020-08-12       Impact factor: 3.017

10.  Acral Vitiligo and Lichen Sclerosus - Association or a Distinct Pattern?: A Clinical and Histopathological Review of 15 Cases.

Authors:  Venkat Ratnam Attili; Sasi Kiran Attili
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.